An Evaluation of Niacinamide in the Treatment of Childhood Schizophrenia
Abstract
The author evaluated 57 schizophrenic children clinically and psychologically before and after a six-month administration of niacinamide. They were separated into three groups: those given niacinamide, those given niacinamide plus a tranquilizer, and those given a placebo. There was no significant difference attributable to niacinamide; also, tests for the "mauve factor" in the urine of 28 of the children were negative.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
